ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 25
Summary
- Conditions
- HIV Infections
- Infection, Human Immunodeficiency Virus
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02075593
- Collaborators
- GlaxoSmithKline
- Investigators
- Study Director: GSK Clinical Trials ViiV Healthcare